Natco Pharma plans five new products for US market
The Rs 850-crore company expects to see organic growth of 15-20 per cent Natco Pharma is preparing to launch about four to five…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ANDA
Wockhardt’s consolidated revenue for Q1FY16 grows by 15 per cent at Rs1141 crore
EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial year 2016. The…
Ajanta Pharma gets approvals for three ANDAs
Montelukast tablets are indicated for the treatment of prophylaxis and chronic treatment of asthma and to relieve symptoms of…
Jubilant Life Sciences receives ANDA approval for Levofloxacin tabs
It is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin…
Aurobindo Pharma receives US FDA approval for Cefixime for oral suspension USP
Cefixime for oral suspension is indicated for the treatment of adults and paediatric patients six months of age or older
Aurobindo Pharma receives US FDA approval
Atracurium Besylate injections are indicated as an adjunct to general anaesthesia
DRL launches docetaxel injection in US
Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose